Clarient CEO Ron Andrews to Present at Jefferies 2010 Global Healthcare Services Conference in New York City

Jan 20, 2010, 06:00 ET from Clarient, Inc.

ALISO VIEJO, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Chief Executive Officer Ron Andrews is scheduled to make an investor presentation at the Jefferies 2010 Global Healthcare Services Conference at 4:00 pm EST on Wednesday, January 27. The conference will be held January 25-27 at the Mandarin Oriental Hotel in New York City.

A live webcast of the presentation will be available via a link provided at An archived replay of the presentation will also be available for a period of 90 days from the date of the presentation at

About Clarient

Clarient combines innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by collaborating with the healthcare community to translate cancer research and development into better patient care.  Clarient's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine has created the need for a centralized resource which provides leading oncology diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory, which provides advanced oncology testing and diagnostic services.  Resulting diagnostic reports and analyses are made available to customers through Clarient's Internet-based portal, PATHSiTE®.  Clarient also plans to develop and market new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, as well as leukemia and lymphoma.


Matt Clawson

Allen & Caron, Inc.

(949) 474-4300

SOURCE Clarient, Inc.